GLP-1 weight-loss medications cause significant muscle loss alongside fat loss, but research shows this can be prevented with adequate protein intake of 1.2 to 1.6 grams per kilogram of body weight daily, combined with regular strength training and vitamin monitoring. According to Gram Research analysis, this comprehensive nutritional approach helps preserve lean mass while maximizing the weight-loss benefits of these medications.
New research shows that popular weight-loss medications like Ozempic and Wegovy help people shed pounds by reducing hunger, but they can also cause muscle loss along with fat loss. According to Gram Research analysis, doctors and nutritionists now recommend eating more protein and monitoring vitamin levels to protect muscle while taking these drugs. The study outlines specific protein targets, which vitamins to watch, and how exercise can help preserve lean muscle mass during treatment. This guidance helps people get the best results from GLP-1 medications while staying healthy.
Key Statistics
A 2026 narrative review in Clinical Nutrition ESPEN found that GLP-1 receptor agonist medications produce substantial weight loss but also cause clinically relevant reductions in lean muscle mass that can be mitigated with protein intake of 1.2-1.6 g/kg body weight daily.
Research synthesized in a 2026 review recommends meal-wise protein targets of 0.3-0.4 grams per kilogram of body weight with 2.5-3 grams of leucine per meal for patients taking GLP-1 medications to preserve muscle during weight loss.
A 2026 clinical nutrition review identified that baseline micronutrient inadequacies are common in people with obesity and may be exacerbated by GLP-1 medications, requiring monitoring of vitamin D, B12, iron, folate, zinc, and thiamine.
According to a 2026 evidence review, progressive resistance training combined with adequate protein intake is essential for maintaining lean mass in patients taking GLP-1 receptor agonist medications for weight loss.
The Quick Take
- What they studied: How people can protect their muscle mass and prevent vitamin deficiencies while taking GLP-1 weight-loss medications like Ozempic and Wegovy.
- Who participated: This review analyzed evidence from multiple studies involving people with obesity taking GLP-1 receptor agonist medications, including those with type 2 diabetes and various health conditions.
- Key finding: While GLP-1 medications cause significant weight loss, they also reduce lean muscle mass. Eating enough protein (1.2 to 1.6 grams per kilogram of body weight daily) and doing strength training can help preserve muscle while losing fat.
- What it means for you: If you’re taking GLP-1 medications, working with a dietitian to eat adequate protein and getting regular strength training may help you lose fat while keeping your muscle. Regular blood tests can catch vitamin deficiencies early. Talk to your doctor before making major dietary changes.
The Research Details
This is a narrative review, meaning researchers examined and summarized findings from multiple existing studies about GLP-1 medications and nutrition. Rather than conducting a new experiment, the authors looked at what randomized controlled trials (the gold standard of research) have shown about how these medications affect body composition, protein needs, and micronutrient status.
The researchers focused on studies that measured actual changes in muscle versus fat using body-composition analysis tools like DXA scans (similar to X-rays that measure bone and muscle density). They then developed practical recommendations based on this evidence for doctors and dietitians to use when treating patients on GLP-1 medications.
This approach is valuable because it pulls together information from many different studies to create a comprehensive guide rather than relying on a single study’s results.
Understanding how GLP-1 medications affect muscle is important because losing muscle can slow metabolism, increase injury risk, and reduce strength and mobility—especially in older adults. By synthesizing evidence from multiple trials, this review provides doctors and dietitians with evidence-based strategies to prevent these problems. The practical framework helps healthcare providers give specific, actionable guidance rather than generic advice.
This review synthesizes evidence from randomized controlled trials, which are considered high-quality research. However, as a narrative review (rather than a systematic review with strict selection criteria), it depends on the authors’ judgment about which studies to include. The recommendations are based on established nutrition science and clinical guidelines, making them more reliable than opinion-based advice. The specific protein targets and monitoring protocols are grounded in peer-reviewed research.
What the Results Show
GLP-1 medications cause substantial weight loss primarily by reducing appetite and food intake. However, research shows that alongside fat loss, these medications also cause a clinically meaningful reduction in lean muscle mass. This muscle loss occurs even though the majority of weight lost is fat.
To preserve muscle during GLP-1 therapy, the research supports daily protein intake of at least 1.2 grams per kilogram of body weight, with some patients benefiting from up to 1.6 grams per kilogram (if they don’t have kidney disease). For practical meal planning, this translates to eating about 0.3 to 0.4 grams of protein per kilogram of body weight at each meal, with 2.5 to 3 grams of leucine (a specific amino acid important for muscle) per meal.
The review emphasizes that protein alone isn’t enough—progressive resistance training (strength exercises) is essential for maintaining and building muscle during weight loss. The combination of adequate protein intake and regular strength training appears to be the most effective approach to preserve lean mass.
People taking GLP-1 medications often have vitamin and mineral deficiencies before starting treatment, and these deficiencies may worsen due to reduced food intake, nausea, or vomiting. The research recommends regular monitoring of vitamin D, vitamin B12, iron, folate, zinc, and thiamine (vitamin B1), especially in high-risk patients.
The review also addresses special populations: older adults may need extra attention to muscle preservation; people with type 2 diabetes may have different nutritional needs; those with kidney disease need modified protein targets; and vegetarians and vegans need careful planning to get enough complete proteins. People with sarcopenic obesity (low muscle mass despite high body weight) require particularly individualized approaches.
This review builds on earlier research showing that weight-loss medications can reduce muscle mass, but it provides more specific, actionable guidance than previous recommendations. It acknowledges that while fat loss is the primary goal, preserving muscle quality and preventing nutritional deficiencies are equally important for long-term health outcomes. The protein targets and monitoring protocols represent a more comprehensive approach than simply recommending ’eat more protein.'
This is a narrative review rather than a systematic review, so the selection of studies included reflects the authors’ judgment rather than predetermined criteria. The review doesn’t provide a meta-analysis (statistical combination of multiple studies), so we can’t quantify exactly how much muscle is lost on average. Individual responses to GLP-1 medications vary widely, so the recommendations may need personalization. Long-term data on outcomes beyond 1-2 years is limited. The review is current as of 2026, but newer evidence may emerge.
The Bottom Line
If you’re taking GLP-1 medications: (1) Work with a registered dietitian to ensure you’re eating 1.2-1.6 grams of protein per kilogram of body weight daily, distributed across meals. (2) Do strength training 2-3 times per week to preserve muscle. (3) Get baseline blood work checking vitamin D, B12, iron, folate, zinc, and thiamine, then recheck periodically. (4) Eat enough calories to support your activity level—don’t restrict calories excessively beyond what the medication naturally causes. These recommendations have strong support from research (high confidence).
Anyone taking GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) should pay attention to these recommendations. This is especially important for older adults, people with type 2 diabetes, those with kidney disease, and people concerned about maintaining strength and mobility. People not taking GLP-1 medications don’t need to follow these specific protocols, though the general principles of adequate protein and strength training apply to anyone losing weight.
You may notice changes in muscle strength within 4-8 weeks of starting strength training. Vitamin deficiencies typically take weeks to months to develop, so regular monitoring (every 3-6 months initially) is important. Body-composition changes (actual muscle loss or preservation) are best measured every 3-6 months using DXA scans or bioelectrical impedance analysis. Long-term benefits of this approach—maintaining strength, mobility, and metabolic health—develop over months to years.
Frequently Asked Questions
Do GLP-1 medications like Ozempic cause muscle loss?
Yes, research shows GLP-1 medications cause some muscle loss alongside fat loss. However, eating enough protein (1.2-1.6 grams per kilogram of body weight daily) and doing strength training can significantly reduce or prevent this muscle loss.
How much protein should I eat if I’m taking GLP-1 weight-loss medication?
Aim for 1.2 to 1.6 grams of protein per kilogram of your body weight daily, spread across meals. For a 200-pound person, this means 110-160 grams daily. Each meal should contain about 30-40 grams of protein with 2.5-3 grams of leucine.
What vitamins should I monitor while taking GLP-1 medications?
Get baseline blood work checking vitamin D, B12, iron, folate, zinc, and thiamine (vitamin B1), especially if you’re at high risk for deficiencies. Recheck these levels every 3-6 months since GLP-1 medications can worsen existing deficiencies through reduced food intake.
Can exercise help preserve muscle while losing weight on GLP-1 drugs?
Yes, progressive resistance training (strength exercises) 2-3 times weekly is essential for preserving muscle during GLP-1 therapy. Combined with adequate protein intake, strength training significantly reduces muscle loss compared to medication alone.
How often should I measure body composition changes on GLP-1 medication?
Get body-composition measurements (DXA scans or bioelectrical impedance analysis) every 3-6 months to track whether you’re preserving muscle while losing fat. This helps your doctor adjust your nutrition and exercise plan if needed.
Want to Apply This Research?
- Log daily protein intake in grams and track it against your personalized target (1.2-1.6 g/kg body weight). For a 200-pound person, this means 110-160 grams daily. Set meal-specific targets of 30-40 grams per meal and track leucine-rich foods (eggs, Greek yogurt, chicken, fish, legumes).
- Add a strength-training session to your calendar 2-3 times weekly. Use the app to log which exercises you complete and track progressive increases in weight or repetitions. Set reminders to eat protein-rich snacks between meals if nausea from medication makes large meals difficult.
- Schedule quarterly body-composition measurements (DXA or BIA) and log results in the app to visualize muscle preservation over time. Set reminders for blood work every 3-6 months to monitor vitamin D, B12, iron, folate, zinc, and thiamine levels. Track any symptoms of deficiency (fatigue, weakness, numbness) and share results with your healthcare provider.
This article summarizes research on nutrition strategies for people taking GLP-1 medications. It is not medical advice. Individual nutritional needs vary based on age, health conditions, kidney function, and other factors. Before making changes to your diet, protein intake, or exercise routine while taking GLP-1 medications, consult with your doctor or a registered dietitian. This is especially important if you have kidney disease, diabetes, or other chronic conditions. Do not use this information to replace professional medical guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.